## **Core Concept**
The question pertains to the diagnostic tests used for breast tumors, focusing on identifying the least useful or relevant test among the given options. Breast tumor diagnosis involves various imaging techniques, biopsies, and sometimes molecular tests.

## **Why the Correct Answer is Right**
Mammography, ultrasound, and MRI are commonly used for assessing breast lesions. Among these, **PET scan (Positron Emission Tomography)** is not a primary diagnostic tool for breast tumors but is sometimes used for staging or assessing metastatic disease. It provides information on the metabolic activity of tissues and can help in identifying distant metastases but is not used for initial diagnosis or characterization of breast lesions.

## **Why Each Wrong Option is Incorrect**
- **Option A (Mammography):** This is a primary screening tool for breast cancer, especially in women over 40. It can detect tumors that are too small to be felt and can identify lesions before symptoms develop.
- **Option B (Ultrasound):** This is useful, especially in younger women or when mammography is inconclusive. It helps differentiate cystic from solid lesions and can guide biopsies.
- **Option C (MRI):** Magnetic Resonance Imaging is highly sensitive for detecting breast lesions, particularly in high-risk women or when other imaging modalities are inconclusive. It provides detailed images of breast tissue.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that while **PET scans** are valuable in oncology for assessing the spread of cancer and monitoring treatment response, they are not used as a first-line diagnostic tool for breast tumors. Instead, they are often used in the context of staging or evaluating recurrent disease.

## **Correct Answer:** D. PET Scan.